Alps Advisors Inc Atara Biotherapeutics, Inc. Transaction History

Alps Advisors Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.69 - $9.84 $448,748 - $941,510	-95,682 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $56,058 - $112,183	-6,642 Reduced 6.49%	95,682 $889,000
Q4 2021 Feb 09, 2022	SELL	$14.7 - $19.89 $22,829 - $30,889	-1,553 Reduced 1.5%	102,324 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $82,215 - $122,740	-6,857 Reduced 6.19%	103,877 $1.86 Million
Q2 2021 Aug 11, 2021	BUY	$12.89 - $16.58 $1.43 Million - $1.84 Million	110,734 New	110,734 $1.72 Million
Q2 2019 Aug 07, 2019	SELL	$19.05 - $41.04 $2.1 Million - $4.52 Million	-110,257 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$28.4 - $41.74 $135,212 - $198,724	4,761 Added 4.51%	110,257 $4.38 Million
Q4 2018 Feb 04, 2019	BUY	$30.9 - $42.97 $780,472 - $1.09 Million	25,258 Added 31.48%	105,496 $3.67 Million
Q3 2018 Oct 25, 2018	BUY	$35.05 - $43.5 $592,520 - $735,367	16,905 Added 26.69%	80,238 $3.32 Million
Q2 2018 Aug 02, 2018	BUY	$35.15 - $51.45 $1.03 Million - $1.51 Million	29,429 Added 86.8%	63,333 $2.33 Million
Q2 2018 Jul 25, 2018	SELL	$35.15 - $51.45 $782,720 - $1.15 Million	-22,268 Reduced 39.64%	33,904 $614,000
Q1 2018 May 01, 2018	BUY	$18.0 - $48.35 $400,824 - $1.08 Million	22,268 Added 65.68%	56,172 $2.19 Million
Q4 2017 Feb 05, 2018	BUY	$13.2 - $18.1 $50,278 - $68,942	3,809 Added 12.66%	33,904 $614,000
Q3 2017 Nov 03, 2017	BUY	$13.25 - $17.05 $398,758 - $513,119	30,095	30,095 $498,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.01B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.